STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[8-K] Anteris Technologies Global Corp. Reports Material Event

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
8-K
Rhea-AI Filing Summary

Anteris Technologies Global Corp. (AVR) furnished quarterly results materials. The company submitted an 8-K noting it filed its Form 10-Q for the quarter ended September 30, 2025, and furnished an accompanying ASX Results Announcement and an ASX Announcement. These materials include unaudited and other historical financial information for the quarter. The exhibits (99.1 and 99.2) are furnished under Item 2.02 and are not deemed filed or incorporated by reference unless a later filing expressly states otherwise.

Positive
  • None.
Negative
  • None.

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549



FORM 8-K



CURRENT REPORT
Pursuant to Section 13 OR 15(d)
of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): November 12, 2025



Anteris Technologies Global Corp.
(Exact name of registrant as specified in its charter)



Delaware
001-42437
99-1407174
(State or Other Jurisdiction of Incorporation)
(Commission File Number)
(I.R.S. Employer Identification No.)

Toowong Tower, Level 3, Suite 302
9 Sherwood Road
Toowong, QLD
Australia
 
4066
(Address of Principal Executive Offices)
 
(Zip Code)

Registrant’s telephone number, including area code: +61 7 3152 3200

Not Applicable
(Former name or former address, if changed since last report)



Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:


Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)


Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))


Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class
 
Trading
Symbol(s)
 
Name of each exchange
on which registered
Common Stock, par value $0.0001 per share
 
AVR
 
The Nasdaq Global Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.



Item 2.02.
Results of Operations and Financial Condition.

On November 12, 2025 USA ET (November 13, 2025 AEST), Anteris Technologies Global Corp. (the “Company”) (i) filed the Form 10-Q for the quarter ended September 30, 2025 with a cover page (the “Results Announcement”) with the Australian Securities Exchange (“ASX”); and (ii) issued an ASX Announcement regarding the Company’s financial results for the quarter ended September 30, 2025, both of which include unaudited and other historical financial information for the quarter ended September 30, 2025. The Results Announcement has been prepared for the purpose of complying with the reporting requirements of the ASX. Copies of the Results Announcement and the ASX Announcement are attached as Exhibits 99.1 and 99.2, respectively, to this Current Report on Form 8-K.

The information in this Item 2.02, including Exhibits 99.1 and 99.2 attached hereto, is being furnished and shall not be deemed to be filed for the purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”), or incorporated by reference into any filing under the Securities Act of 1933 or the Exchange Act, unless such subsequent filing specifically references this Current Report on Form 8-K.

Item 9.01.
Financial Statements and Exhibits.

(d) Exhibits.

The following exhibits are filed with this Current Report on Form 8-K:

Exhibit
No.
 
Description
99.1
 
Results Announcement, as filed with the ASX, for the quarter ended September 30, 2025
     
99.2
 
ASX Announcement regarding financial results for the quarter ended September 30, 2025
     
104
 
Cover Page Interactive Data File (embedded within the Inline XBRL document)


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


Anteris Technologies Global Corp.

 
Date: November 12, 2025






By:
/s/ Wayne Paterson

Name:
Wayne Paterson

Title:
Vice Chairman and Chief Executive Officer



FAQ

What did Anteris Technologies (AVR) announce on the 8-K?

It filed its Form 10-Q for the quarter ended September 30, 2025 and furnished ASX results materials as Exhibits 99.1 and 99.2.

Which period do the furnished results for AVR cover?

They cover the quarter ended September 30, 2025 and include unaudited, historical financial information.

Are the AVR exhibits considered filed with the SEC?

No. The information in Item 2.02, including Exhibits 99.1 and 99.2, is being furnished and is not deemed filed.

What exhibits are included with the AVR 8-K?

Exhibit 99.1 is the ASX Results Announcement for the quarter, and Exhibit 99.2 is an ASX Announcement regarding those results.

When did Anteris Technologies take this action?

On November 12, 2025 USA ET (November 13, 2025 AEST).

Does the 8-K incorporate the exhibits by reference?

Only if a subsequent filing specifically references this 8-K for incorporation by reference.
ANTERIS TECHNOLOGIES GLOBAL

NASDAQ:AVR

AVR Rankings

AVR Latest News

AVR Latest SEC Filings

AVR Stock Data

152.02M
39.42M
0.21%
47.59%
2.29%
Medical Instruments & Supplies
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Link
Australia
EAGAN